Latest Form 4 insider transactions

Alistair N Sporck, VP Contactor Business Unit of Aehr Test Systems, reported a transaction in 295 shares of common stock on October 12, 2026.

Mark James King, Exec Chairman & Interim CEO and a Director of Jack In The Box Inc, sold 7,013 shares of common stock on October 13, 2026 for $12.18 per share.

Andrew Leaver, Chief Executive Officer of Arqit Quantum Inc., reported multiple transactions in common stock on October 12, 2026.

Catherine Kiernan Hogan, Chief Operating Officer of Accenture plc, sold 700 shares of common stock on October 12, 2026.

Opaleye Management Inc. reported changes in beneficial ownership of Grace Therapeutics, Inc. common stock on October 8, 2026.

Joseph Michael Lubin, a Director of SharpLink Gaming, Inc., sold 5,676,952 shares of common stock on October 8, 2026 for $8.39 per share.

David A Henry, Chief Financial Officer of Myomo, Inc., reported multiple transactions in common stock on October 9, 2026.

Meghan Frank, Chief Financial Officer of lululemon athletica inc., received 42,328 shares of common stock on October 9, 2026.

Thomas Marks, EVP, Business Development of Evi Industries, Inc., reported a transaction in 831 shares of common stock on October 9, 2026.

Stephen Paul Patak, Chief Revenue Officer of BurTech Acquisition Corp., reported multiple transactions in common stock on October 12, 2026.

Henry M Nahmad, Chairman, CEO & President, a Director and 10% owner of Evi Industries, Inc., reported a transaction in 8,198 shares of common stock on October 9, 2026.

Paul R Gudonis, Chief Executive Officer and a Director of Myomo, Inc., received 8,363 shares of common stock on October 9, 2026.

Edward J Rapp, a Director of Xos, Inc., received 1,814 shares of common stock on October 10, 2026.

Ryan A King, Co-Founder and a Director of Chime Financial, Inc., sold 50,300 shares of common stock on October 9, 2026.

Robert Lazar, Chief Financial Officer of Evi Industries, Inc., reported multiple transactions in common stock on October 9, 2026.

Quang X Pham, Chairman and CEO, a Director and 10% owner of Cadrenal Therapeutics, Inc., received 200,000 shares of common stock on October 9, 2026.

Lee Scott Golden, a Director of Cadrenal Therapeutics, Inc., received 75,000 shares of common stock on October 9, 2026.

John Raymond Murphy, a Director of Cadrenal Therapeutics, Inc., received 75,000 shares of common stock on October 9, 2026.

Jeffrey Scott Cole, Chief Operating Officer of Cadrenal Therapeutics, Inc., received 150,000 shares of common stock on October 9, 2026.

Chantal Wessels, a Director of VenHub Global, Inc., received 25,000 shares of common stock on October 9, 2026.

Shoushana Ohanessian, a Director of VenHub Global, Inc., received 25,000 shares of common stock on October 9, 2026.

Gene Liu, Chief Accounting Officer of Atlassian Corp, sold 337 shares of common stock on October 12, 2026 for $210.00 per share.

Glynn Wilson, a Director of Cadrenal Therapeutics, Inc., received 75,000 shares of common stock on October 9, 2026.

Shahan Artin Ohanessian, Chief Executive Officer, a Director and 10% owner of VenHub Global, Inc., received 25,000 shares of common stock on October 9, 2026.

Chris Koopmans, a Director of Skyworks Solutions, Inc., received 1,722 shares of common stock on October 12, 2026.

Jeffrey Adam Rubin, a Director of VenHub Global, Inc., received 25,000 shares of common stock on October 9, 2026.

Nader Kabbani, a Director of VenHub Global, Inc., received 25,000 shares of common stock on October 9, 2026.

Richard L Clemmer, a Director of Skyworks Solutions, Inc., received 1,722 shares of common stock on October 12, 2026.

Wes Cummins, CEO; Chairman and a Director of Applied Digital Corp., reported multiple transactions in common stock on October 10, 2026.

James Budge, Chief Financial Officer of Hinge Health, Inc., sold 47,720 shares of common stock on October 12, 2026.